Association of Cancer Care Centers

13/11/2025

Biomarker testing is key to providing personalized patient care.
In support of the first annual Cancer Biomarker Awareness Day, hosted by LUNGevity Foundation, ACCC shares valuable resources to raise awareness of biomarker testing and its benefits for patients.

• View a 5-part video spotlight (https://hubs.li/Q03T7MZ00) on a successful, community-based program led by Marc Roth, MD, co-lead of the Center for Precision Oncology at Saint Luke's Cancer Institute in Kansas City, Missouri.

• Read a blog about tools and takeaways from large-scale projects to support cancer programs new to biomarker testing, as well as those looking to step up their testing workflows: https://hubs.li/Q03T7LnY0.

To help cancer care teams in the community setting implement genetic testing into patient care, the Association of Cancer Care Centers (ACCC) offers this spo...

11/11/2025

In recognition of both Native American Heritage Month and Veterans Day, ACCC honors the enduring legacy of military service among American Indian and Alaska Native (AI/AN) Veterans.

Research indicates that AI/AN Veterans are screened for certain cancers at lower rates than their peers. Adding to the challenge, many AI/AN Veterans are eligible for care through multiple systems, which can create logistical and administrative complications. Moreover, rural communities including tribal lands and reservations face barriers related to oncologist access, distance, terrain, and digital connectivity.

In October 2021, multiple government agencies signed a renewed memorandum of understanding (MOU) to advance health equity for AI/AN Veterans. For cancer care providers, understanding this interagency collaboration informs how care can be coordinated across complex systems and reinforces the importance of trust, cultural respect, and community engagement in caring for AI/AN Veterans with the dignity and quality they deserve.

Read more on our blog: https://hubs.li/Q03SGDpb0

06/11/2025

In metastatic breast cancer, resistance to therapy remains one of the most challenging aspects to care. A key driver of resistance in hormone receptor-positive, HER2-negative disease is the ESR1 mutation, a genetic change that alters the estrogen receptor and limits the effectiveness of certain standard therapies.

🎙️In this episode, CANCER BUZZ speaks with Eleonora Teplinsky, MD, FASCO, head of breast and gynecologic medical oncology at Valley-Mount Sinai Comprehensive Cancer Care, about how the ESR1 mutation shapes treatment decisions and effective communication strategies, such as the “lock-and-key” model.

🎙️ Then the podcast speaks with Maimah Karmo, president and CEO of Tigerlily Foundation, about the importance of communicating with patients in ways that foster clarity and compassion through relatable analogies.

🎧 Listen: https://hubs.li/Q03S41Gy0

Valley Health; Tigerlily Foundation

06/11/2025

Treating patients with relapsed/refractory follicular lymphoma (R/R FL) requires a multidisciplinary approach that considers key domains such as financial navigation and patient support, clinical trials awareness and integration, toxicity management, and much more. Dive into Oncology Issues for a comprehensive guide to delivering and coordinating care that recognizes the highly individualized and evolving nature of R/R FL: https://hubs.li/Q03R_jSZ0.

06/11/2025

Tennessee oncology professionals: Reserve your seat (https://hubs.li/Q03RYycr0) for a live dinner workshop on operationalizing bispecific antibodies (BsAbs) in cancer care.

Hear from experts at Vanderbilt-Ingram Cancer Center:
o Muhamed Baljevic, MD, FACP
o Douglas B. Johnson, MD, MSCI
o Kathryn E. Kennedy, APRN
o Sarah Profitt, PharmD, BCOP

📍 Vanderbilt-Ingram Cancer Center | Nashville, TN
🕠 Dinner: 5:30 PM | Program: 6:00 - 8:00 PM CST

Gain practical insights on infusion management, workflow optimization, and care coordination to bring BsAbs from the academic setting into your practice. Dinner will be provided, and parking is complimentary.

04/11/2025

Navigating ESR1 mutations in metastatic breast cancer can be difficult for patients, given the complexity of clinical implications and uncertainties around the need for additional genomic testing. This month’s Oncology Issues features a guide with evidence-based strategies to communicate clearly and compassionately, deliver timely information and personalized treatment plans, and address common patient questions and concerns: https://hubs.li/Q03Ry1Wp0.

03/11/2025

COVID-19’s impact on communities of color underscored deep inequities in health care. A new study, featured in Oncology Issues, sheds light on how patients with cancer managed care disruptions and highlights valuable insights for developing more resilient, patient-centered support systems: https://hubs.li/Q03Rk2h70.

31/10/2025

Through personalized care, data-driven insights, and strong community partnerships, Self Regional Healthcare is empowering patients in rural communities to regain strength, reduce the risk of cancer recurrence, and live with purpose through a model that integrates exercise into survivorship care. Read the latest Oncology Issues for a deep dive into their program: https://hubs.li/Q03R6WBM0.

29/10/2025

ACCC is proud to partner with NCODA, Hematology/Oncology Pharmacy Association - HOPA, and Oncology Nursing Society on the new Patient Education Sheets (PES) website, a centralized, easy-to-access hub designed to support patients with trusted, up-to-date cancer care information.

This powerful collaboration brings together expertise across oncology disciplines to deliver high-quality educational resources that empower patients and enhance care conversations.

Whether you're a clinician, pharmacist, nurse, or patient advocate, the PES website is built to support our members’ work and improve patient understanding. “When patients are navigating a cancer diagnosis and treatment, our goal is to equip providers with clear, accessible tools that simplify the treatment plan—so they can focus on delivering compassionate, effective care.” –ACCC Executive Director Meagan O’Neill Access these resources now: https://hubs.li/Q03QS2JZ0.

29/10/2025

ACCC’s recent blog shares 2 stories from patients with relapsed/refractory follicular lymphoma that illustrate how the principles outlined in our Effective Practice Guide (patient-centered decision-making, multidisciplinary collaboration, and strong partnerships between academic & community practices) can be applied in daily practice.

Read more: https://hubs.li/Q03QMlJd0

28/10/2025

October is , and CDK inhibitors continue to play a critical role in advancing treatment and improving outcomes for patients with breast cancer. 🩷 Explore key insights and our new suite of CDK inhibitor resources at https://hubs.li/Q03QzqJc0.

27/10/2025

The George Washington University Cancer Center serves a racially, ethnically, and socioeconomically diverse population across Washington, D.C., northern Virginia, and southern Maryland. Their Breast Cancer Program has found that a community-informed model is most successful for managing care and adverse events related to CDK4/6 inhibitors.

In this episode, CANCER BUZZ speaks with Pavani Chalasani, MD, MPH, director of the division of hematology/oncology at the George Washington University Cancer Center, about the flexible and collaborative team design that allows for culturally responsive and comprehensive care for their patients with breast cancer.

🎧 Listen: https://hubs.li/Q03QkD5s0